tetano
Editor, Senior Moderator
Open Forum Infect Dis
. 2021 Feb 2;8(3)
fab061.
doi: 10.1093/ofid/ofab061. eCollection 2021 Mar.
Establishment of Monoclonal Antibody Standards for Quantitative Serological Diagnosis of SARS-CoV-2 in Low-Incidence Settings
Archana Thomas[SUP] 1 [/SUP], William B Messer[SUP] 2 3 [/SUP], Donna E Hansel[SUP] 4 [/SUP], Daniel N Streblow[SUP] 5 [/SUP], Steven C Kazmierczak[SUP] 4 [/SUP], Zoe L Lyski[SUP] 2 3 [/SUP], Zhengchun Lu[SUP] 2 3 [/SUP], Mark K Slifka[SUP] 1 [/SUP]
Affiliations
Abstract
Background: Serological confirmation of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical for understanding the dynamics of the pandemic and determining seroprevalence rates within afflicted communities. Common challenges with SARS-CoV-2 serological assays include poor analytical specificity and sensitivity and lack of a serological standard for quantitative assessment of antibody titers.
Methods: To overcome these obstacles, we developed a quantitative enzyme-linked immunosorbent assay based on an optimized 2-dimensional screening assay that utilizes SARS-CoV-2 receptor binding domain (RBD) of spike protein and SARS-CoV-2 spike S1 subunit.
Results: A total of 4 SARS-CoV-2-reactive monoclonal antibodies were evaluated for use as serum standards for calibrating assays performed on different days or by different laboratories. This approach provided quantitative analysis of hospitalized reverse transcription polymerase chain reaction-confirmed COVID-19 cases that in some cases reached >100 ?g/mL. The assay demonstrated 72% sensitivity based on time points ranging from 2 to 52 days post-symptom onset, with 100% sensitivity at time points measured ?13 days post-symptom onset and 100% specificity.
Conclusions: Using these optimized reagents and serological standards, we believe this approach will be useful for sensitive and specific determination of seroconversion rates and quantitatively measuring the durability of antiviral antibody responses following SARS-CoV-2 infection or vaccination.
Keywords: COVID-19; ELISA; IgG; SARS-CoV-2; coronavirus; coronavirus disease 2019; diagnostics; severe acute respiratory syndrome coronavirus 2.
. 2021 Feb 2;8(3)
fab061.doi: 10.1093/ofid/ofab061. eCollection 2021 Mar.
Establishment of Monoclonal Antibody Standards for Quantitative Serological Diagnosis of SARS-CoV-2 in Low-Incidence Settings
Archana Thomas[SUP] 1 [/SUP], William B Messer[SUP] 2 3 [/SUP], Donna E Hansel[SUP] 4 [/SUP], Daniel N Streblow[SUP] 5 [/SUP], Steven C Kazmierczak[SUP] 4 [/SUP], Zoe L Lyski[SUP] 2 3 [/SUP], Zhengchun Lu[SUP] 2 3 [/SUP], Mark K Slifka[SUP] 1 [/SUP]
Affiliations
- PMID: 33723513
- PMCID: PMC7928679
- DOI: 10.1093/ofid/ofab061
Abstract
Background: Serological confirmation of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical for understanding the dynamics of the pandemic and determining seroprevalence rates within afflicted communities. Common challenges with SARS-CoV-2 serological assays include poor analytical specificity and sensitivity and lack of a serological standard for quantitative assessment of antibody titers.
Methods: To overcome these obstacles, we developed a quantitative enzyme-linked immunosorbent assay based on an optimized 2-dimensional screening assay that utilizes SARS-CoV-2 receptor binding domain (RBD) of spike protein and SARS-CoV-2 spike S1 subunit.
Results: A total of 4 SARS-CoV-2-reactive monoclonal antibodies were evaluated for use as serum standards for calibrating assays performed on different days or by different laboratories. This approach provided quantitative analysis of hospitalized reverse transcription polymerase chain reaction-confirmed COVID-19 cases that in some cases reached >100 ?g/mL. The assay demonstrated 72% sensitivity based on time points ranging from 2 to 52 days post-symptom onset, with 100% sensitivity at time points measured ?13 days post-symptom onset and 100% specificity.
Conclusions: Using these optimized reagents and serological standards, we believe this approach will be useful for sensitive and specific determination of seroconversion rates and quantitatively measuring the durability of antiviral antibody responses following SARS-CoV-2 infection or vaccination.
Keywords: COVID-19; ELISA; IgG; SARS-CoV-2; coronavirus; coronavirus disease 2019; diagnostics; severe acute respiratory syndrome coronavirus 2.